A reassessment of triazolam.


Concern over the safety of triazolam is reflected in the actions taken against the drug world-wide by many drug regulatory agencies, ranging from restrictions in duration of use and dosage to banning of the drug. There is extensive scientific literature documenting that triazolam produces frequent and severe psychiatric adverse events: during drug… (More)
DOI: 10.3233/JRS-1996-9102


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics